Inhibitor Therapeutics Inc (INTI): HedgePath Pharmaceuticals Announces Gran...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Monday, 06/19/2017 11:48:08 AM

Monday, June 19, 2017 11:48:08 AM

HedgePath Pharmaceuticals Announces Granting of Type-C Meeting Request by FDA and Provides Positive Clinical Trial Update.
TAMPA, Fla., May 30, 2017 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (HPPI)

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 11:02:01 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 01:54:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 07:49:19 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 06:42:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 06:33:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 01:15:19 PM

InvestorsHub NewsWire

Only $200 per official company press release!